Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: Results of an open-label study
- 1 January 2003
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (1), 298-308
- https://doi.org/10.1016/s0149-2918(03)90041-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlledBMJ, 2001
- Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinicJournal of the American Academy of Dermatology, 2001
- Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating)New England Journal of Medicine, 2001
- Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experienceEuropean Journal of Neurology, 1999
- The quality of life in acne: a comparison with general medical conditions using generic questionnairesBritish Journal of Dermatology, 1999
- A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosisBritish Journal of Dermatology, 1999
- Botulinum toxin for focal hyperhidrosis: technical considerations and improvements in applicationBritish Journal of Dermatology, 1998
- Focal HyperhidrosisArchives of Dermatology, 1998
- Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palmsBritish Journal of Dermatology, 1997
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994